CareDx, Inc. (CDNA)

Slide locked Sign in to view

Slide schematic 6/6

list 1/1 paragraph 2/2 quote 1/1 source-note 1/1 title 1/1

Components 6

bullet paragraph paragraph pull-quote source-note headline

Tools 2

Thesis archetype slide · 70%

III. Clinical Data Show that AlloSure is Insensitive in Discriminating Kidney Rejection, with an Unacceptable Miss Rate

Villain slide slide · 80%

CareDx clearly positions AlloSure as a kidney rejection test that makes up for the weaknesses of serum creatinine...

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

fraud-exposure 80%

The slide systematically deconstructs the clinical claims of a medical product to argue it is ineffective.

Find anything